Patient’s recognition level of medical terms as estimated by pharmacists

Table 3 Difference between pharmacists with and without clinical trial experience with respect to patients’ recognition level of the 90 medical terms

Group	Medical term	Estimated by the pharmacists^a (%)
		Experience of clinical trials
		Yes (n = 59)	No (n = 153)	Test
		Know	Know
C	Clinical pass	33.9	17.0	*
D	Phase one clinical trial	35.6	18.3	*
D	Phase two clinical trial	32.2	15.7	**
D	Phase three clinical trial	32.2	15.7	**
D	GCP	27.1	15.0	*
E	Ataxia	39.0	24.8	*
E	Malignant syndrome	39.0	24.2	*
E	Drug-related parkinsonism	37.3	22.9	*
E	Ventricular tachycardia	32.2	15.0	**
E	Alveolar hemorrhage	27.1	13.1	*

^a1 means “I do not think that patients know”. 3 means “I cannot tell clearly whether the patient knows or not”, 5 means “I think that patients know.” In analyzing, 4 and 5 out of 1–5 were used as “I think that patients know”
n.s. not significant
χ ² test: ** p < 0.01,* p < 0.05

ISSN: 1347-4715